DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» ISCOM
ISCOM
Preparation Of' Immunostimulating Complexes
Matrix-M™ Adjuvation Broadens Protection Induced by Seasonal Trivalent Virosomal Influenza Vaccine
Natural and Synthetic Saponins As Vaccine Adjuvants
The Iscom Structure As an Immune-Enhancing Moiety: Experience with Viral Systems
An Immune Stimulating Complex (ISCOM) Subunit Rabies Vaccine Protects Dogs and Mice Against Street Rabies Challenge
Mechanisms and Performances of Adjuvants in Vaccine Immunogenicity
(12) United States Patent (10) Patent No.: US 6,352,697 B1 Cox Et Al
SAPONIN from QUILLAJA BARK PURIFIED Sigma Prod. No. S4521 Storage: Room Temperature
Iscoms and Immunostimulation with Viral Antigens
Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses Via Modulation of Immunodominance
Saponins from Quillaja Saponaria and Quillaja Brasiliensis: Particular Chemical Characteristics and Biological Activities
Protection, Systemic IFN, and Antibody Responses Induced by an ISCOM
Protection, Systemic IFN , and Antibody Responses Induced by An
Vaccine Iscoms and ISCOMATRIXTM
Equine Influenza Virus and Vaccines
By Specific Targeting of B Cells Systemic Immunity to Incorporated Antigens Vector Promotes Priming of Mucosal and the Combined
Immunostimulating Complexes
Immunostimulating Complexes Clinical Potential in Vaccine Development
Top View
Multifunctional Immunoadjuvants for Use in Minimalist Nucleic Acid Vaccines
The Veterinary Journal 199 (2014) 268–274
Novel Iscoms from Quillaja Brasiliensis Saponins Induce Mucosal And
Vaccine Rhesus Macaques by a Nonclassical ISCOM Core-Specific Immune Responses Primed in Characterization of Hepatitis C Virus
NIH Public Access Author Manuscript Curr Drug Ther
Since January 2020 Elsevier Has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID- 19
T Cells + Cross-Priming of CD8 Cells in Vivo Leading to Effective
Immunological Basis of Vaccination